An antigenomic strategy for treating heteroplasmic mtDNA disorders
- 22 May 2001
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 49 (1-2) , 121-125
- https://doi.org/10.1016/s0169-409x(01)00130-2
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Peptide nucleic acid delivery to human mitochondriaGene Therapy, 1999
- Mitochondria in neuromuscular disordersBiochimica et Biophysica Acta (BBA) - Bioenergetics, 1998
- Selective targeting of bioactive compounds to mitochondriaTrends in Biotechnology, 1997
- Selective inhibition of mutant human mitochondrial DNA replication in vitro by peptide nucleic acidsNature Genetics, 1997
- Chimeric green fluorescent protein as a tool for visualizing subcellular organelles in living cellsCurrent Biology, 1995
- Myoclonic epilepsy with ragged‐red fibers (MERRF) syndrome: Report of a Chinese family with mitochondrial DNA point mutation in tRNALys geneMuscle & Nerve, 1994
- PNA hybridizes to complementary oligonucleotides obeying the Watson–Crick hydrogen-bonding rulesNature, 1993
- Sequence-Selective Recognition of DNA by Strand Displacement with a Thymine-Substituted PolyamideScience, 1991
- Injection of mitochondria into human cells leads to a rapid replacement of the endogenous mitochondrial DNACell, 1988
- Sequence and organization of the human mitochondrial genomeNature, 1981